Posted by TriedEveryMedication on November 9, 2011, at 11:29:30
currently in phase II trials:
GLYX-13 preclinical data presented at a major medical meeting showed that it demonstrated:
Robust antidepressant-like activity.
-An immediate onset of effectthe antidepressant effects of GLYX-13 were evident within 20 minutes of administering a single dose.
-A long-acting duration of effectdemonstrating an antidepressant-like effect lasting at least two weeks after a single dose.
-No signs of CNS-related side effects, achieving a therapeutic index of 500 or morean unprecedented result for drugs targeting the NMDA receptor.
poster:TriedEveryMedication
thread:1002023
URL: http://www.dr-bob.org/babble/20111027/msgs/1002023.html